Management of Hypoplastic Right Posterior Communicating Artery
Diagnostic Evaluation
- Non-invasive imaging with CTA or MRA should be performed to fully characterize the cerebrovascular anatomy when hypoplastic PCoA is identified, particularly in patients with neurological symptoms referable to the posterior circulation 1, 2
- The imaging workup should specifically assess presence and severity of carotid or vertebral artery stenosis, as these become clinically significant in the setting of incomplete collateral circulation 1
- Posterior circulation vessel patency and flow dynamics should be assessed using MRA or CTA rather than ultrasound alone 1, 3
Medical Management
- All patients with identified hypoplastic PCoA and atherosclerotic risk factors require aggressive medical therapy following the same standards as extracranial carotid atherosclerosis 1, 2, 4
- Aspirin 75-325 mg daily should be administered to prevent myocardial infarction and ischemic events 1, 4
- Intensive atherosclerotic risk factor modification including blood pressure control, lipid management, smoking cessation, and diabetes management is recommended 1, 2
- Antiplatelet therapy is particularly critical given the increased thromboembolic risk from compromised collateral circulation 1
Surgical and Interventional Considerations
- Carotid endarterectomy or stenting should be strongly considered in patients with hypoplastic PCoA who develop symptomatic carotid stenosis, even when symptoms manifest as posterior circulation events 1
- Symptomatic carotid stenosis >50% with incomplete circle of Willis warrants consideration for carotid intervention 1
- Asymptomatic bilateral carotid occlusions or unilateral carotid occlusion with incomplete circle of Willis warrant evaluation for vertebral artery disease 1
Surveillance Strategy
- Serial non-invasive imaging is reasonable at extended intervals for patients with hypoplastic PCoA and known atherosclerotic disease to assess progression and exclude development of new lesions 1, 3
- Surveillance should focus on both anterior and posterior circulation vessels 1
- Termination of surveillance is reasonable when the patient is no longer a candidate for cardiovascular intervention 1